Correlation Between Vor Biopharma and Tenaya Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vor Biopharma and Tenaya Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vor Biopharma and Tenaya Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vor Biopharma and Tenaya Therapeutics, you can compare the effects of market volatilities on Vor Biopharma and Tenaya Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vor Biopharma with a short position of Tenaya Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vor Biopharma and Tenaya Therapeutics.

Diversification Opportunities for Vor Biopharma and Tenaya Therapeutics

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Vor and Tenaya is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Vor Biopharma and Tenaya Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tenaya Therapeutics and Vor Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vor Biopharma are associated (or correlated) with Tenaya Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tenaya Therapeutics has no effect on the direction of Vor Biopharma i.e., Vor Biopharma and Tenaya Therapeutics go up and down completely randomly.

Pair Corralation between Vor Biopharma and Tenaya Therapeutics

Considering the 90-day investment horizon Vor Biopharma is expected to generate 3.04 times less return on investment than Tenaya Therapeutics. But when comparing it to its historical volatility, Vor Biopharma is 1.75 times less risky than Tenaya Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Tenaya Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  208.00  in Tenaya Therapeutics on August 28, 2024 and sell it today you would earn a total of  88.00  from holding Tenaya Therapeutics or generate 42.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vor Biopharma  vs.  Tenaya Therapeutics

 Performance 
       Timeline  
Vor Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vor Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Vor Biopharma is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Tenaya Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Tenaya Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Tenaya Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Vor Biopharma and Tenaya Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vor Biopharma and Tenaya Therapeutics

The main advantage of trading using opposite Vor Biopharma and Tenaya Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vor Biopharma position performs unexpectedly, Tenaya Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenaya Therapeutics will offset losses from the drop in Tenaya Therapeutics' long position.
The idea behind Vor Biopharma and Tenaya Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Correlations
Find global opportunities by holding instruments from different markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges